Alpha Lipoic Acid for Vitiligo: Antioxidant Evidence Reviewed
Alpha lipoic acid (ALA) is an antioxidant compound that occurs naturally in mitochondria and is available as a dietary supplement. It has attracted interest in vitiligo research based on the oxidative stress hypothesis — the idea that elevated hydrogen peroxide and reactive oxygen species in vitiligo skin contribute to melanocyte damage, making antioxidants potentially beneficial as adjunctive treatment.
The evidence for ALA in vitiligo is limited to small trials, mostly studying it as an adjunct to phototherapy. Here is an honest assessment of what that evidence shows.
The oxidative stress hypothesis in vitiligo
Vitiligo skin shows elevated markers of oxidative stress compared to normal skin — higher hydrogen peroxide levels, reduced antioxidant enzyme activity (catalase, superoxide dismutase, glutathione peroxidase), and increased lipid peroxidation products. These differences are documented consistently across studies.
Whether this oxidative stress is a cause of vitiligo or a consequence of the immune attack on melanocytes is less clear. It may be bidirectional — oxidative stress can damage melanocytes directly and also activate immune pathways, while the autoimmune process produces reactive oxygen species that create more oxidative stress.
If oxidative stress contributes to the disease, then antioxidant supplementation might reduce the oxidative burden on surviving melanocytes — either protecting them from destruction or creating a better environment for repigmentation during treatment.
What alpha lipoic acid does
ALA is a particularly versatile antioxidant because it is both fat-soluble and water-soluble, allowing it to function in different cellular compartments. It also regenerates other antioxidants (vitamins C and E, glutathione). Its mitochondrial role makes it relevant to cellular energy production and oxidative stress management.
In vitiligo research, the interest is in whether supplemental ALA can reduce the elevated oxidative stress burden in vitiligo skin and improve the response to phototherapy.
Clinical evidence
The most cited trial (Dell’Anna et al., 2007, Italy) was a small randomised study of 35 vitiligo patients comparing:
- NbUVB + combination supplement (ALA, vitamin C, vitamin E, polyunsaturated fatty acids)
- NbUVB + placebo
After six months:
- The supplement group showed significantly better repigmentation than the placebo group
- Mean repigmented area was approximately 47% in the supplement group vs 18% in placebo group
The limitation: the “supplement” was a combination product including multiple antioxidants — not ALA alone. It is impossible to attribute the benefit specifically to ALA versus the other components (vitamins C, E, and polyunsaturated fatty acids, all of which have antioxidant activity).
Subsequent studies of antioxidant combinations in vitiligo (including ALA as a component) have shown similar trends — modest benefit as phototherapy adjuncts. None have isolated ALA as a single variable.
Dosing
Based on studies, typical ALA doses for vitiligo have ranged from 100–600mg daily. The supplement used in the Dell’Anna trial provided ALA alongside vitamins C and E — the specific ALA dose was 100mg twice daily.
ALA is available as a supplement without prescription. It should be taken with food (some people experience nausea on an empty stomach). R-ALA (the active isomer) is more potent per gram than racemic mixtures but more expensive.
Safety
ALA is well-tolerated at standard doses. Possible mild side effects include nausea, skin rash, and occasionally low blood sugar at higher doses (relevant for diabetic patients). It interacts with some thyroid medications — important for vitiligo patients who also have thyroid disease and are on thyroid hormones. A pharmacist or physician can advise on timing.
At higher doses (600mg+ daily), some patients report insomnia or anxiety.
Practical place in treatment
ALA is most rationally used as an adjunct to phototherapy — part of an antioxidant support strategy rather than a primary treatment. The evidence does not support ALA alone producing meaningful vitiligo repigmentation without concurrent phototherapy.
The combination antioxidant approach (ALA + vitamins C and E) may be more effective than any single antioxidant — consistent with the biology of antioxidant networks where compounds regenerate each other. If using antioxidant supplements, a combination product with ALA, vitamin C, and vitamin E in evidence-based doses is more defensible than high-dose ALA alone.
Compared to polypodium leucotomos, ALA has less vitiligo-specific clinical evidence. Both are low-risk supplements worth considering if you are on phototherapy and want adjunctive antioxidant support.
The best supplements for vitiligo treatment guide covers the full supplement landscape, and the vitiligo treatment options comparison situates supplements within the broader hierarchy of evidence-based treatments.
